Alnylam Pharmaceuticals, Inc. (BMV:ALNY)
8,380.00
-180.00 (-2.10%)
At close: Sep 2, 2025
66.60% (1Y)
| Market Cap | 726.49B -0.1% |
| Revenue (ttm) | 58.88B +53.2% |
| Net Income | 799.08M |
| EPS | 6.05 |
| Shares Out | n/a |
| PE Ratio | 909.17 |
| Forward PE | 32.20 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 45 |
| Average Volume | 344 |
| Open | 8,380.00 |
| Previous Close | 8,560.00 |
| Day's Range | 8,380.00 - 8,380.00 |
| 52-Week Range | 4,900.00 - 8,560.00 |
| Beta | n/a |
| RSI | 76.36 |
| Earnings Date | Feb 12, 2026 |